Send me a link:

*Text messaging rates may apply.

 Dow Down 1.88% Nasdaq Down 2.09%

Alexion Pharmaceuticals, Inc. (ALXN)

-NasdaqGS
158.99 4.69(2.87%) Jul 31, 4:00PM EDT
Prev Close:163.68
Open:161.03
Bid:120.00 x 100
Ask:167.62 x 200
1y Target Est:197.05
Beta:0.51
Earnings Date:Oct 22 - Oct 27 (Est.)
Day's Range:158.35 - 163.49
52wk Range:100.89 - 185.43
Volume:1,445,809
Avg Vol (3m):1,204,600
Market Cap:31.45B
P/E (ttm):96.12
EPS (ttm):1.65
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ALXN

Comparison

Symbol% ChgMkt Cap
ALXNDown 2.87%31.45B
AMGN96.69B
BAX40.53B

Key Statistics

Forward P/E (1 yr):27.51
P/S (ttm):16.85
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :5.01
Quarterly EPS Est (Sep-14) :1.15
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):1.02

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback